Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Charite - Universitaetsmedizin Berlin |
| Country | Germany |
| Start Date | Jan 01, 2023 |
| End Date | Dec 31, 2026 |
| Duration | 1,460 days |
| Number of Grantees | 13 |
| Roles | Participant; Associated Partner; Coordinator; Third Party |
| Data Source | European Commission |
| Grant ID | 101095540 |
IMMEDIATE aims to investigate and explore the diet-microbiome-immunometabolism-axis as a sensor for health-to-disease transition and evaluate strategies to maintain an individuals well-being. Chronic inflammation is the major root of most diseases.
Understanding of this process preceding organ dysfunction or damage and identification of biomarkers in the pre-symptomatic stage and risk but also resilience factors of health-to-disease transition will enable targeted and personalized interventions to prevent irreversible organ damage.
Metabolites of gut microbiota are key messengers between diet, microbiota and host, maintaining the balance of pro- and anti-inflammation.
Our study takes advantage of cutting-edge omics technologies available within the IMMEDIATE consortium in conjunction with available clinical data and biospecimens from ongoing observational studies, enrolling healthy subjects and individuals in the pre-disease stage but with largely distinct environmental and dietary modulators, including a cohort of kidney transplant recipients in whom renal function has been reset to baseline.
The identification of clinical and omics-derived biomarkers will by employing AI algorithms - yield a personalized risk / resilience score of chronic inflammation and thus a better prediction of an individuals risk of transition towards disease.
A proof-of-concept intervention study with the anti-inflammatory microbe Akkermansia muciniphila will be conducted to test whether deflections of the microbiome-metabolite-immune axis can be reverted on the biomarker level but also with respect to clinical outcomes and overall well-being.
Mobile apps developed by the IMMEDIATE consortium in collaboration with patient organizations tracking numerous lifestyle-related measures and providing guidance and feedback on these aspects will empower individuals to adopt and integrate these knowledge-based health interventions into their own lives, hereby self-managing their own health.
The Akkermansia Company; Zadig Srl; Imperial College of Science Technology and Medicine; Weizmann Institute of Science; Eurice European Research and Project Office Gmbh; Max Delbrueck Centrum Fuer Molekulare Medizin in Der Helmholtz-Gemeinschaft (Mdc); Pomorski Uniwersytet Medyczny W Szczecinie; Universitaetsklinikum Essen; Charite - Universitaetsmedizin Berlin; Research and Innovation Services Doo Za Usluge; Universitatsklinikum Erlangen; Sanprobi Spolka Z Ograniczona Odpowiedzialnoscia Spolka Komandytowa; Bundesverband Niere E.V.
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant